Skip to main content
Log in

Total Pancreatectomy: Indications, Operative Technique, and Postoperative Sequelae

  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Total pancreatectomy has been used to treat both benign and malignant disease of the pancreas, but its use has been limited by concerns about management of the apancreatic state with its attendant total endocrine and exocrine insufficiency. Here, we review the indications for total pancreatectomy, operative technique, and improvements in the postoperative management of patients. Total pancreatectomy remains a viable option in the treatment of intractable pain associated with chronic pancreatitis, multicentric or extensive neuroendocrine tumors, patients with familial pancreatic cancer with premalignant lesions, and in patients with intraductal papillary mucinous neoplasia with diffuse ductal involvement or invasive disease. Improvements in postoperative management include auto-islet cell transplantation, advances in insulin formulations, and the use of glucagon rescue therapy which allow much tighter control of blood glucose than previously possible. This markedly lessens the risk of life-threatening hypoglycemia and decreases the risk of long-term complications, resulting in improved quality of life for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

Abbreviations

IPMN:

intraductal papillary mucinous neoplasia

References

  1. Sauve L. Des pancreatectemies et specialement de la pancreatectomie cephalique. Rev Chir 1908;37:113–152.

    Google Scholar 

  2. Rockey EW. Total pancreatectomy for carcinoma: Case Report. Ann Surg 1943;118:603–611.

    Article  PubMed  CAS  Google Scholar 

  3. Warren KW, Poulantzas JK, June GA. Life after total pancreatectomy for pancreatitis. Ann Surg 1966;164:830–834.

    Article  PubMed  CAS  Google Scholar 

  4. Stone WM. Chronic pancreatitis: results of Whipple’s resection and total pancreatectomy. Arch Surg 1988;123(7):815–819.

    PubMed  CAS  Google Scholar 

  5. Gall FP, Muhe E, Gebhardt C. Results of partial and total pancreaticoduodenectomy in 117 patients with chronic pancreatitis. World J Surg 1981;5(2):269–275.

    Article  PubMed  CAS  Google Scholar 

  6. Braasch JW, Vito L, Nugent FW. Total pancreatectomy of end-stage chronic pancreatitis. Ann Surg 1978;188(3):317–322.

    Article  PubMed  CAS  Google Scholar 

  7. Sarr MG, Sakorafas GH. Incapacitating pain of chronic pancreatitis: a surgical perspective of what is known and what is not known. Gastrointest Endosc 1999;49:S85–S89.

    Article  PubMed  CAS  Google Scholar 

  8. Warshaw AL, Banks PA, Fenandez-del Castillo C. Treatment of pain in chronic pancreatitis. Gastroenterology 1998;115(3):765–776.

    Article  PubMed  CAS  Google Scholar 

  9. Gruessner RWG, Sutherland DER, Dunn DL, Najarian JS, Jie T, Hering BJ, Gruessner AC. Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis. J Am Coll Surg 2004;198:559–567.

    Article  PubMed  Google Scholar 

  10. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes 1989;38:140–142.

    PubMed  Google Scholar 

  11. Rodriguez-Rilo HL, Ahmad SA, D’Alessio D, Iwanaga Y, Kim J, Choe KA, Moulton JS, Martin J, Pennington LJ, Soldano DA, Biliter J, Martin SP, Ulrich CD, Somogyi L, Welge J, Matthews JB, Lowy AM. Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg 2003;7(8):978–989.

    Article  PubMed  Google Scholar 

  12. Clayton HA, Davies JE, Pollard CA, White SA, Musto PP, Dennison AR. Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the Leichester General Hospital. Transplantation 2003;76:92–98.

    Article  PubMed  Google Scholar 

  13. Ricordi C, Inverardi L, Kenyon NS, Goss J, Bertuzzi F, Alejandro R. Requirements for success in clinical islet transplantation. Transplantation 2005;79(10):1298–1300 (May 27).

    Article  PubMed  Google Scholar 

  14. Buchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z’graggen K. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 2003;138:1310–1314.

    Article  PubMed  Google Scholar 

  15. Lin JW, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg 2004;8(8):951–959 (Dec).

    Article  PubMed  Google Scholar 

  16. Munoz-Bongrand N, Sauvanet A, Denys A, Sibert A, Vilgrain V, Belghiti J. Conservative management of pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg 2004;199(2):198–203 Aug.

    Article  PubMed  Google Scholar 

  17. Collins JJ, Craighead JE, Brooks JR. Rationale for total pancreatectomy for carcinoma of the pancreatic head. N Engl J Med 1966;274:599–602.

    Article  PubMed  Google Scholar 

  18. Van Heerden JA, ReMine WH, Weiland LH, McIlrath DC, ILstrup DM. Total pancreatectomy for ductal adenocarcinoma of the pancreas: Mayo Clinic experience. Am J Surg 1981;142:308–311.

    Article  PubMed  Google Scholar 

  19. Ihse I, Lilja P, Anresjo B, Bengmark S. Total pancreatectomy for cancer: an appraisal of 65 cases. Ann Surg 1977;186:675–680.

    Article  PubMed  CAS  Google Scholar 

  20. Kloppel G, Lohse T, Bosslet K, Ruckert K. Ductal adenocarcinoma of the head of the pancreas: incidence of tumor involvement beyond the whipple resection line. Histological and immunocytochemical analysis of 37 total pancreatectomy specimens. Pancreas 1987;2:170–175.

    Article  PubMed  CAS  Google Scholar 

  21. Motojima K, Urano T, Nagata Y, Shiku H, Tsurfune T, Kanematsu T. Detection of point mutations in the Kristen-ras oncogene provides evidence for the multicentricity of pancreatic adenocarcinoma. Ann Surg 1993;217(2):138–143.

    Article  PubMed  CAS  Google Scholar 

  22. Ihse I, Anderson H, Andren-Sandberg A. Total pancreatectomy for cancer of the pancreas: is it appropriate? World J Surg 1996;20:288–294.

    Article  PubMed  CAS  Google Scholar 

  23. Sarr MG, Behrns KE, vanHeerden JA. Total pancreatectomy: an objective analysis of its use in pancreatic cancer. Hepatogastroenterol 1993;40:418–421.

    CAS  Google Scholar 

  24. Karpoff H, Klimstra DS, Brennan MF, Conlon KC. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 2001;136:44–47.

    Article  PubMed  CAS  Google Scholar 

  25. Bartsch DK. Familial pancreatic cancer. Br J Surg 2003;90:386–387.

    Article  PubMed  CAS  Google Scholar 

  26. Lynch HT, Lanspa SJ, Fitzgibbons RJ, Smyrk T, Fitzsimmons ML, McClellan J. Familial pancreatic cancer: genetic pathology review. Nebr Med J 1989;74:109–112.

    PubMed  CAS  Google Scholar 

  27. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Griffin C, Cameron JL, Yeo CJ, Kern S, Hruban RH. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64(7):2634–2638.

    Article  PubMed  CAS  Google Scholar 

  28. Hahn SA, Greenhalf B, Ellis I, Sina-Frey M, Rieder H, Korte B, Gerdes B, Kress R, Ziegler A, Raeburn JA, Campra D, Grutzmann R, Rehder H, Rothmund M, Schmiegel W, Neoptolemos JP, Bartsch DK. BRCAZ germline mutations in familial pancreatic cancer. J Natl Cancer Inst 2003;5:180–181.

    Google Scholar 

  29. Eberle MA, Pfutzer R, Pogue-Geile KL, Bronner MP, Crispin D, Kimmey MB, et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32–34. Am J Hum Genet 2002;70:1044–1048.

    Article  PubMed  CAS  Google Scholar 

  30. Greenhalf W, McFaul C, Earl J, Howes N, Neoptolemos J, Kress R, Sina-Frey M, Rieder H, Hahn SA, Bartsch D. Anticipation in familial pancreatic cancer. Gut 2006;2155(2):252–258.

    Google Scholar 

  31. Reider H, Sina-Frey M, Ziegler A, Hahn SA, Przypadlo E, Kress R, et al. German national case collection of familial pancreatic cancer-clinical-genetic analysis of the first 21 families. Onkologie 2002;25:262–266.

    Article  Google Scholar 

  32. Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, et al. Increased risk of incident pancreatic cancer among first-degree relatives with familial pancreatic cancer. Clin Cancer Res 2001;7:738–744.

    PubMed  CAS  Google Scholar 

  33. Brentnall TA. Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 2000;84(3):707–718.

    Article  PubMed  CAS  Google Scholar 

  34. Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology 2001;1(5):477–485.

    Article  PubMed  CAS  Google Scholar 

  35. Charpentier KP, Brentnall TA, Bronner MP, Byrd D, Christopher M. A new indication for pancreas transplantation: high grade pancreatic dysplasia. Clin Transplant 2004;18:105–107.

    Article  PubMed  Google Scholar 

  36. Thompson GB, Service FJ, van Heerden JA, Carney JA, Charboneau JW, O’Brien PC, Grant CS. Reoperative insulinomas, 1927 to 1992: an institutional experience. Surgery 1993;114(6):1196–1206.

    PubMed  CAS  Google Scholar 

  37. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA, Norton JA. Lethality of multiple endocrine neoplasia type I. World J Surg 1998;22:581–587.

    CAS  Google Scholar 

  38. Thompson NW. Invited commentary. World J Surg 1998;22(6):586–587.

    Google Scholar 

  39. Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 2003;138:859–866.

    Article  PubMed  Google Scholar 

  40. Ohhashi K, Murakami Y, Takekoshi T, Ohta H, Ohhashi I. Four cases of “mucin-producing” cancer of the pancreas on specific findings of the papilla of Vater. Progress of Digestive Endoscopy 1982;20:348–351.

    Google Scholar 

  41. Rickaert F, Cremer M, Devière J, Tavares L, Lambilliotte JP, Schroder S, et al. Intraductal mucin-hypersecreting neoplasms of the pancreas: a clinicopathologic study of eight patients. Gastroenterology 1991;101:512–519.

    PubMed  CAS  Google Scholar 

  42. Jang JY, Kim SW, Ahn YJ, Yoon YS, Choi MG, Lee KU, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005;12(2):124–132 (Feb).

    Article  PubMed  Google Scholar 

  43. Sarr MG, Kendrick ML, Nagorney DM, Thompson GB, Farley DR, Farnell MB. Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. Surg Clin North Am 2001;81(3):497–509.

    Article  PubMed  CAS  Google Scholar 

  44. Cuillerier E, Cellier C, Palazzo L, Deviere J, Wind P, Rickaert F, Cugnenc PH, Cremer M, Barbier JP. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000;95(2):441–445.

    Article  PubMed  CAS  Google Scholar 

  45. Azar C, Van de Stadt J, Rickaert F, Deviere M, Baize M, Kloppel G, Gelin M, Cremer M. Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut 1996;39(3):457–464.

    PubMed  CAS  Google Scholar 

  46. Raimondo M, Tachibana I, Urrutia R, Burgart LJ, DiMagno EP. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2002;97(10):2553–2558 (Oct.).

    Article  PubMed  Google Scholar 

  47. Obara T, Maguchi H, Saitoh Y, Itoh A, Arisato S, Ashida T, Nishino N, Ura H, Namiki M. Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changes. Am J Gastroenterol 1993;88:564–569.

    PubMed  CAS  Google Scholar 

  48. Doi K, Prentki M, Yip C, Muller WA, Jeanreneaud B, Vrainic M. Identical biological effects of pancreatic glucagons and a purified moiety of canine gastric immunoreactive glucagons. J Clin Invest 1979;63:525–531.

    Article  PubMed  CAS  Google Scholar 

  49. Muller WA, Brennan MF, Tan MH, Aoki TT. Studies of glucagon secretion in pancreatectomised patients. Diabetes 1974;23:512–516.

    PubMed  CAS  Google Scholar 

  50. Vigili de Kreutzenberg S, Maifreni L, Lisato G, Riccio A, Trevisan R, Tiengo A, DelPrato S. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagons infusion. J Clin Endocrinol Metab 1990;70:1023–1029.

    PubMed  CAS  Google Scholar 

  51. Muller WA, Brennan MF, Tan MH, Aoki TT. Studies of glucagon secretion in pancreatectomized patients. Diabetes 1974;23(6):512–516 (Jun).

    PubMed  CAS  Google Scholar 

  52. Slezak LA, Andersen DK. Pancreatic resection: effects on glucose metabolism. World J Surg 2001;25:452–460.

    Article  PubMed  CAS  Google Scholar 

  53. Boyle PJ. Alteration in brain glucose metabolism induced by hypoglycaemia in man. Diabetologia 1997;40(Suppl 2):S69–S74.

    Article  PubMed  CAS  Google Scholar 

  54. Horie H, Matsuyama Namba M, et al. Responses of catecholamines and other counterregulatory hormones to insulin-induced hypoglycemia in totally pancreatectomized patients. J Clin Endocrinol Metab 1984;59:1193–1196.

    PubMed  CAS  Google Scholar 

  55. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effective of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988;37:901–907.

    Article  PubMed  CAS  Google Scholar 

  56. Butler PC, Rizza RA. Regulation of carbohydrate metabolism and response to hypoglycemia. Endocrinol Metab Clin N Am 1989;18(1):1–25 (Mar).

    CAS  Google Scholar 

  57. Tattersall RB. Brittle diabetes revisited: the Third Arnold Bloom Memorial Lecture. Diabet Med 1997;14(2):99–110 (Feb.).

    Article  PubMed  CAS  Google Scholar 

  58. Radermecker RP, Scheen AJ. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. Diabetes/metab Res Rev 2004;20(3):178–188 (May–Jun).

    Article  CAS  Google Scholar 

  59. Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MW. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes 2005;54(4):1100–1107.

    Article  PubMed  CAS  Google Scholar 

  60. Bajorunas DR, Fortner JG, Jaspan J, Sherwin RS. Total pancreatectomy increases the metabolic response to glucagon in humans. J Clin Endocrinol Metab 1986;63:439–446.

    Article  PubMed  CAS  Google Scholar 

  61. Tankjoh K, Tomita R, Mera K, Hayashi N. Metabolic modulation by concomitant administration of insulin and glucagon in pancreatectomy patients. Hepatogastroentereology 2002;49(44):538–543.

    Google Scholar 

  62. Petrides A, DeFronzo RA. Glucose metabolism in cirrhosis: a review with some perspective for the future. Diabetes/metab Rev 1989;5:691–709.

    Article  CAS  Google Scholar 

  63. Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pracitce and Research in Clinical Gastroenterology 2004;18:947–955.

    Article  Google Scholar 

  64. Dressler CM, Fortner JG, McDermott K, Bajorunas DR. Metabolic consequences of (regional) total pancreatectomy. Ann Surg 1991;214:131–140.

    Article  Google Scholar 

  65. Buchler M, Freiss H, Muller M, Wheatley A, Berger H. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg 1994;65:458–467.

    Google Scholar 

  66. Easter DW, Cuschieri A. Total pancreatectomy with preservation of the duodenum and pylorus for chronic pancreatitis. Ann Surg 1991;214:575–580.

    Article  PubMed  CAS  Google Scholar 

  67. Alexakis N, Ghaneh P, Connor S, Raraty M, Sutton R, Neoptolemos JP. Duodenum- and spleen preserving total pancreatectomy for end-stage chronic pancreatitis. Br J Surg 2003;90:1401–1408.

    Article  PubMed  CAS  Google Scholar 

  68. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004;88(4):787–835 (Jul).

    Article  PubMed  CAS  Google Scholar 

  69. Landoni L, Salvia R, Festa L, Muselli P, Giardino A, Butturini G, Falconi M, Bassi C, Pederzoli. Quality of life after total pancreatectomy. Ten-year experience. J Pancreas (Online) 2004;5(5 Suppl):441.

    Google Scholar 

  70. Billings BJ, Christein JD, Harmsen WS, Harrington JR, Chari ST, Que FG, Farnell MB, Nagorney DM, Sarr MG. Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg 2005;9(8):1059–1067 (Nov–Dec).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Diane M. Simeone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heidt, D.G., Burant, C. & Simeone, D.M. Total Pancreatectomy: Indications, Operative Technique, and Postoperative Sequelae. J Gastrointest Surg 11, 209–216 (2007). https://doi.org/10.1007/s11605-006-0025-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-006-0025-7

Keywords

Navigation